Compensation Agreements in the Biotechnology Industry
1,238 Contracts & Agreements
- 2seventy bio, Inc. (1 contract)
- 4D Molecular Therapeutics Inc (1)
- 89bio, Inc. (3)
- AbbVie Inc. (3)
- ACADIA PHARMACEUTICALS INC (5)
- Acorda Therapeutics (1)
- Acumen Pharmaceuticals, Inc. (2)
- Adagio Therapeutics, Inc. (2)
- Adamas Pharmaceuticals Inc (4)
- ADMA BIOLOGICS, INC. (1)
- ADURO BIOTECH, INC. (4)
- Adverum Biotechnologies, Inc. (6)
- Aerovate Therapeutics, Inc. (2)
- AGENUS INC (4)
- AgeX Therapeutics, Inc. (2)
- Aimmune Therapeutics, Inc. (2)
- AKCEA THERAPEUTICS, INC. (3)
- Akebia Therapeutics, Inc. (6)
- Akero Therapeutics, Inc. (3)
- Akouos, Inc. (1)
- ALBIREO PHARMA, INC. (11)
- Alector, Inc. (3)
- Alexion Pharmaceuticals (1)
- Aligos Therapeutics, Inc. (1)
- Allakos Inc. (5)
- Allena Pharmaceuticals, Inc. (4)
- Allogene Therapeutics, Inc. (4)
- ALNYLAM PHARMACEUTICALS, INC. (2)
- ALPINE IMMUNE SCIENCES, INC. (5)
- Altimmune, Inc. (2)
- ALX ONCOLOGY HOLDINGS INC (2)
- AMARILLO BIOSCIENCES INC (1)
- AMARIN CORP PLC (1)
- Amgen Inc. (14)
- Amplitude Healthcare Acquisition Corp (2)
- Anchiano Therapeutics Ltd. (1)
- Anika Therapeutics (2)
- Annexon, Inc. (4)
- Apellis Pharmaceuticals, Inc. (3)
- Applied Molecular Transport Inc. (1)
- Aptinyx Inc. (3)
- Aravive, Inc. (3)
- Arcellx, Inc. (1)
- Arcus Biosciences, Inc. (6)
- Arcutis Biotherapeutics, Inc. (1)
- ARDELYX, INC. (4)
- ARENA PHARMACEUTICALS INC (14)
- ARROWHEAD PHARMACEUTICALS, INC. (1)
- Arsanis, Inc. (1)
- Artiva Biotherapeutics, Inc. (1)
- ARYA Sciences Acquisition Corp II (5)
- Atreca, Inc. (1)
- aTYR PHARMA INC (1)
- Aura Biosciences, Inc. (1)
- Avid Bioservices, Inc. (2)
- Avidity Biosciences, Inc. (4)
- Avita Therapeutics, Inc. (1)
- Axovant Sciences Ltd. (2)
- Ayala Pharmaceuticals, Inc. (1)
- AZIYO BIOLOGICS, INC. (1)
- BCTG Acquisition Corp. (3)
- Beam Therapeutics Inc. (5)
- BeiGene, Ltd. (7)
- BELLICUM PHARMACEUTICALS, INC (8)
- BICYCLE THERAPEUTICS Ltd (5)
- BioAtla, Inc. (1)
- BIOCEPT INC (1)
- BIOMARIN PHARMACEUTICAL INC (9)
- Biomea Fusion, Inc. (1)
- Biostage, Inc. (2)
- BioXcel Therapeutics, Inc. (1)
- Black Diamond Therapeutics, Inc. (3)
- bluebird bio, Inc. (1)
- Bone Biologics Corp (1)
- BRAINSTORM CELL THERAPEUTICS INC. (6)
- BriaCell Therapeutics Corp. (2)
- BridgeBio Pharma, Inc. (2)
- BullFrog AI Holdings, Inc. (1)
- Cabaletta Bio, Inc. (4)
- CALADRIUS BIOSCIENCES, INC. (9)
- Calyxt, Inc. (1)
- CAPRICOR THERAPEUTICS, INC. (1)
- CareDx, Inc. (6)
- Caribou Biosciences, Inc. (17)
- CASTLE BIOSCIENCES INC (7)
- CATABASIS PHARMACEUTICALS INC (2)
- CATALYST BIOSCIENCES, INC. (3)
- Cellectar Biosciences, Inc. (1)
- Cellular Biomedicine Group, Inc. (1)
- Checkmate Pharmaceuticals, Inc. (1)
- Checkpoint Therapeutics, Inc. (2)
- Chelsea Worldwide Inc. (1)
- ChemoCentryx, Inc. (7)
- CHIMERIX INC (6)
- Cidara Therapeutics, Inc. (3)
- CLEVELAND BIOLABS INC (2)
- Codiak BioSciences, Inc. (2)
- CohBar, Inc. (1)
- Conatus Pharmaceuticals Inc. (3)
- CONCERT PHARMACEUTICALS, INC. (8)
- Constellation Alpha Capital Corp. (2)
- CONSTELLATION PHARMACEUTICALS INC (1)
- CONTRAFECT Corp (2)
- Corbus Pharmaceuticals Holdings, Inc. (1)
- Cortexyme, Inc. (1)
- Crinetics Pharmaceuticals, Inc. (2)
- CTI BIOPHARMA CORP (12)
- Cue Biopharma, Inc. (3)
- Cullinan Oncology, LLC (2)
- CURIS INC (6)
- Cyclerion Therapeutics, Inc. (2)
- CytoDyn Inc. (4)
- Cytokinetics, Incorporated (6)
- CYTORI THERAPEUTICS, INC. (1)
- Deciphera Pharmaceuticals, Inc. (4)
- Denali Therapeutics Inc. (5)
- Design Therapeutics, Inc. (2)
- Dynamics Special Purpose Corp. (1)
- DYNAVAX TECHNOLOGIES CORP (7)
- Eagle Pharmaceuticals, Inc. (1)
- Editas Medicine, Inc. (3)
- Eidos Therapeutics, Inc. (1)
- Eiger BioPharmaceuticals, Inc. (6)
- Emergent BioSolutions Inc. (3)
- Entasis Therapeutics Holdings Inc. (4)
- Entrada Therapeutics, Inc. (2)
- ENZON PHARMACEUTICALS, INC. (6)
- Epizyme, Inc. (5)
- Equillium, Inc. (6)
- Erasca, Inc. (2)
- Esperion Therapeutics, Inc. (2)
- Evelo Biosciences, Inc. (4)
- EXACT SCIENCES CORP (16)
- Exelixis (36)
- FATE THERAPEUTICS INC (6)
- FIBROGEN INC (7)
- FIVE PRIME THERAPEUTICS INC (1)
- Flex Pharma, Inc. (3)
- Flexion Therapeutics Inc (7)
- Forma Therapeutics Holdings, Inc., (4)
- Frequency Therapeutics, Inc. (2)
- G1 Therapeutics, Inc. (4)
- Galecto Inc. (4)
- Galera Therapeutics, Inc. (4)
- Gamida Cell Ltd. (1)
- Gemphire Therapeutics Inc. (2)
- GENELUX CORP (2)
- Generation Bio Co. (2)
- GENEREX BIOTECHNOLOGY CORP (3)
- Genprex, Inc. (3)
- GeoVax Labs, Inc. (2)
- GERON CORP (11)
- Gilead Sciences (4)
- Global Blood Therapeutics, Inc. (4)
- GLYCOMIMETICS INC (7)
- Gossamer Bio, Inc. (5)
- Graphite Bio, Inc. (3)
- Gritstone Oncology, Inc. (2)
- GTX INC (25)
- GX Acquisition Corp. (1)
- HALOZYME THERAPEUTICS INC (2)
- HARBOR DIVERSIFIED, INC. (1)
- Harpoon Therapeutics, Inc. (3)
- HCW Biologics Inc. (1)
- HilleVax, Inc. (2)
- HISTOGENICS CORP (2)
- Homology Medicines, Inc. (4)
- HUMANIGEN, INC (2)
- Icosavax, Inc. (1)
- IDEAYA Biosciences, Inc. (2)
- IDERA PHARMACEUTICALS, INC. (6)
- IGM Biosciences, Inc. (6)
- Imago BioSciences, Inc. (2)
- Immix Biopharma, Inc. (1)
- IMMUCELL CORP (1)
- Immuneering Corp (4)
- ImmunoCellular Therapeutics, Ltd. (2)
- IMMUNOGEN INC (10)
- Immunome Inc. (4)
- IN8BIO, INC. (5)
- Inhibrx, Inc. (1)
- Inozyme Pharma, Inc. (1)
- Inspyr Therapeutics, Inc. (5)
- Instil Bio, Inc. (1)
- Intec Parent Inc. (1)
- Intec Pharma Ltd. (2)
- Intellia Therapeutics, Inc. (3)
- INTERCEPT PHARMACEUTICALS, INC. (4)
- INTREXON CORP (1)
- Intrinsic Medicine, Inc. (1)
- IONIS PHARMACEUTICALS INC (3)
- IOVANCE BIOTHERAPEUTICS, INC. (1)
- IRONWOOD PHARMACEUTICALS INC (5)
- Janux Therapeutics, Inc. (2)
- Jounce Therapeutics, Inc. (7)
- KalVista Pharmaceuticals, Inc. (2)
- Karyopharm Therapeutics Inc. (2)
- KBL MERGER CORP. IV (1)
- Keros Therapeutics, Inc. (1)
- Kezar Life Sciences, Inc. (4)
- Kiniksa Pharmaceuticals, Ltd. (2)
- Kinnate Biopharma Inc. (2)
- Kodiak Sciences Inc. (2)
- Kronos Bio, Inc. (3)
- Kura Oncology, Inc. (4)
- Kymera Therapeutics, Inc. (3)
- Leisure Acquisition Corp. (1)
- LEXICON PHARMACEUTICALS, INC. (12)
- LianBio (1)
- Ligand Pharmaceuticals Incorporated (1)
- LIXTE BIOTECHNOLOGY HOLDINGS, INC. (1)
- Locust Walk Acquisition Corp. (5)
- Lyell Immunopharma, Inc. (2)
- MADRIGAL PHARMACEUTICALS, INC. (6)
- MANNKIND CORP (3)
- MATEON THERAPEUTICS INC (7)
- Matinas BioPharma Holdings, Inc. (2)
- MEI Pharma, Inc. (1)
- MeiraGTx Holdings plc (6)
- MERRIMACK PHARMACEUTICALS INC (1)
- Mersana Therapeutics, Inc. (2)
- Merus N.V. (2)
- Metacrine, Inc. (3)
- Millendo Therapeutics, Inc. (5)
- MiMedx Group, Inc. (7)
- Minerva Neurosciences, Inc. (3)
- MIRAGEN THERAPEUTICS, INC. (1)
- Mirati Therapeutics, Inc. (10)
- Mirum Pharmaceuticals, Inc. (2)
- Moderna, Inc. (4)
- Molecular Templates, Inc. (4)
- Momenta Pharmaceuticals, Inc. (13)
- Myovant Sciences Ltd. (4)
- Myriad Genetics, Inc. (12)
- NantKwest, Inc. (1)
- Natera, Inc. (6)
- NEUROTROPE BIOSCIENCE, INC. (2)
- Neurotrope, Inc. (1)
- NexImmune, Inc. (2)
- NextCure, Inc. (2)
- Nkarta, Inc. (4)
- NORTHWEST BIOTHERAPEUTICS INC (1)
- NTN BUZZTIME INC (2)
- Nuvalent, Inc. (2)
- Ohr Pharmaceutical Inc (3)
- Olema Pharmaceuticals, Inc. (2)
- Omega Therapeutics, Inc. (1)
- OPGEN INC (3)
- Ophthotech Corp. (4)
- Oric Pharmaceuticals, Inc. (2)
- Outlook Therapeutics, Inc. (2)
- Ovid Therapeutics Inc. (3)
- Oyster Point Pharma, Inc. (2)
- PDL BIOPHARMA, INC. (1)
- PepGen Inc. (2)
- PharmaCyte Biotech, Inc. (4)
- PhaseBio Pharmaceuticals Inc (5)
- PIERIS PHARMACEUTICALS, INC. (7)
- PLURISTEM THERAPEUTICS INC (4)
- PMV Pharmaceuticals, Inc. (4)
- POLARITYTE, INC. (3)
- PORTOLA PHARMACEUTICALS INC (7)
- Poseida Therapeutics, Inc. (4)
- Praxis Precision Medicines, Inc. (3)
- PRECISION BIOSCIENCES INC (3)
- Prevail Therapeutics Inc. (2)
- Progenics Pharmaceuticals, Inc. (2)
- Prometheus Biosciences, Inc. (2)
- Protagenic Therapeutics, Inc. (1)
- PROTEON THERAPEUTICS INC (4)
- PROTEOSTASIS THERAPEUTICS, INC. (2)
- PUMA BIOTECHNOLOGY, INC. (6)
- Radius Health, Inc. (4)
- RAPT Therapeutics, Inc. (4)
- RECURSION PHARMACEUTICALS, INC. (1)
- REGENXBIO Inc. (6)
- Regulus Therapeutics Inc. (6)
- Relay Therapeutics, Inc. (3)
- Reneo Pharmaceuticals, Inc. (2)
- RenovoRx, Inc. (6)
- Replimune Group, Inc. (1)
- Retrophin, Inc. (4)
- Revolution Medicines, Inc. (4)
- REXAHN PHARMACEUTICALS, INC. (3)
- RHYTHM PHARMACEUTICALS, INC. (8)
- RIGEL PHARMACEUTICALS INC (4)
- RITTER PHARMACEUTICALS INC (1)
- ROCKET PHARMACEUTICALS, INC. (1)
- Rubius Therapeutics, Inc. (1)
- Sage Therapeutics, Inc. (5)
- Sana Biotechnology, Inc. (3)
- Sarepta Therapeutics, Inc. (1)
- Savara Inc (2)
- SEATTLE GENETICS INC (2)
- SELECTA BIOSCIENCES INC (7)
- Sensei Biotherapeutics, Inc. (2)
- SERA PROGNOSTICS, INC. (2)
- Seres Therapeutics, Inc. (6)
- Shattuck Labs, Inc. (2)
- Shuttle Pharmaceuticals Holdings, Inc. (1)
- Sigilon Therapeutics, Inc. (2)
- Silverback Therapeutics, Inc. (3)
- SOLENO THERAPEUTICS INC (1)
- Solid Biosciences Inc. (7)
- SOPHIRIS BIO INC. (1)
- Sorrento Therapeutics, Inc. (2)
- Spero Therapeutics, Inc. (4)
- SPHERIX INC (6)
- Spring Bank Pharmaceuticals, Inc. (4)
- SpringWorks Therapeutics, Inc. (3)
- SPRUCE BIOSCIENCES, INC. (4)
- SQZ Biotechnologies Co (3)
- Stellar Biotechnologies, Inc. (1)
- SUNESIS PHARMACEUTICALS INC (7)
- Syndax Pharmaceuticals Inc (3)
- SYNLOGIC, INC. (4)
- Syros Pharmaceuticals, Inc. (1)
- T2 Biosystems, Inc. (10)
- Talaris Therapeutics, Inc. (2)
- Taysha Gene Therapies, Inc. (2)
- TENAX THERAPEUTICS, INC. (3)
- Tenaya Therapeutics, Inc. (3)
- TG THERAPEUTICS, INC. (1)
- Tocagen Inc (5)
- Tracon Pharmaceuticals, Inc. (7)
- Translate Bio, Inc. (3)
- TREVENA INC (4)
- Turning Point Therapeutics, Inc. (4)
- Tyra Biosciences, Inc. (2)
- U.S. Stem Cell, Inc. (3)
- Ultragenyx Pharmaceutical Inc. (2)
- Unity Biotechnology, Inc. (5)
- Unum Therapeutics Inc. (3)
- UroGen Pharma Ltd. (1)
- VACCINEX, INC. (1)
- Vaccitech plc (1)
- Vaxart, Inc. (1)
- Vera Therapeutics, Inc. (2)
- Vericel Corp (5)
- Vertex Pharmaceuticals Inc (16)
- Verve Therapeutics, Inc. (3)
- VICAL INC (3)
- Viela Bio, Inc. (2)
- Vigil Neuroscience, Inc. (1)
- Viking Therapeutics, Inc. (5)
- Vir Biotechnology, Inc. (3)
- VITAL THERAPIES INC (4)
- Vor Biopharma Inc. (1)
- Xencor Inc (8)
- Xilio Therapeutics, Inc. (2)
- Y-mAbs Therapeutics, Inc. (1)
- Zai Lab Ltd (3)
- Zentalis Pharmaceuticals, LLC (5)
- Director Compensation Policy (AgeX Therapeutics, Inc., Filed With SEC on April 1, 2024)
- Amended and Restated Outside Director Compensation Policy (RenovoRx, Inc., Filed With SEC on April 1, 2024)
- Director Compensation Policy effective December 7, 2023 (Cue Biopharma, Inc., Filed With SEC on March 28, 2024)
- Vera Therapeutics, Inc. Non-employee Director Compensation Policy, as amended December 6, 2023 (Vera Therapeutics, Inc., Filed With SEC on March 27, 2024)
- Erasca, Inc. Non-Employee Director Compensation Program (Erasca, Inc., Filed With SEC on March 27, 2024)
- Q32 Bio Inc. Non-Employee Director Compensation Policy (Homology Medicines, Inc., Filed With SEC on March 27, 2024)
- Gamida Cell Ltd. Amended and Restated Compensation Policy (Gamida Cell Ltd., Filed With SEC on March 27, 2024)
- Amended and Restated Non-Employee Director Compensation Policy, as currently in effect (GLYCOMIMETICS INC, Filed With SEC on March 27, 2024)
- eFFECTOR Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Program (Locust Walk Acquisition Corp., Filed With SEC on March 26, 2024)
- Summary of Non-Employee Director Compensation (LEXICON PHARMACEUTICALS, INC., Filed With SEC on March 25, 2024)
- Outside Director Compensation Policy (Graphite Bio, Inc., Filed With SEC on March 22, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (Instil Bio, Inc., Filed With SEC on March 21, 2024)
- Third Amended and Restated Non-Employee Director Compensation Policy (Cabaletta Bio, Inc., Filed With SEC on March 21, 2024)
- Non-Employee Director Compensation Policy, as amended (Silverback Therapeutics, Inc., Filed With SEC on March 21, 2024)
- Amended Independent Director Compensation Policy (BeiGene, Ltd., Filed With SEC on March 20, 2024)
- Non-Employee Director Compensation Guidelines (ALPINE IMMUNE SCIENCES, INC., Filed With SEC on March 20, 2024)
- Non-Employee Director Compensation Policy (SERA PROGNOSTICS, INC., Filed With SEC on March 20, 2024)
- Non-Employee Director Compensation Policy (Design Therapeutics, Inc., Filed With SEC on March 19, 2024)
- Compensation Clawback Policy (LIXTE BIOTECHNOLOGY HOLDINGS, INC., Filed With SEC on March 19, 2024)
- Outside Director Compensation Policy (Tenaya Therapeutics, Inc., Filed With SEC on March 18, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (Tocagen Inc, Filed With SEC on March 18, 2024)
- Anika Therapeutics, Inc. Non-Employee Director Compensation Policy (restated as of December 22, 2023) (Anika Therapeutics, Filed With SEC on March 15, 2024)
- Mirum Pharmaceuticals, Inc. Non-Employee Director Compensation Policy, as amended (Mirum Pharmaceuticals, Inc., Filed With SEC on March 15, 2024)
- Non-Employee Director Compensation Policy (as amended December 5, 2023) (IN8BIO, INC., Filed With SEC on March 14, 2024)
- Non-Employee Director Compensation Policy (as amended November 30, 2021) (IN8BIO, INC., Filed With SEC on March 14, 2024)
- Non-Employee Director Compensation Policy (Allogene Therapeutics, Inc., Filed With SEC on March 14, 2024)
- Non-Employee Director Compensation Policy (Kezar Life Sciences, Inc., Filed With SEC on March 14, 2024)
- Third Amended and Restated Non-Employee Director Compensation Program, effective January 1, 2024 (Akebia Therapeutics, Inc., Filed With SEC on March 14, 2024)
- Non-Employee Director Compensation Policy (aTYR PHARMA INC, Filed With SEC on March 14, 2024)
- Non-Employee Director Compensation Policy, as amended (Spero Therapeutics, Inc., Filed With SEC on March 13, 2024)
- Amended and Restated Non-Employee Director Compensation Plan, effective February 14, 2024 (Black Diamond Therapeutics, Inc., Filed With SEC on March 12, 2024)
- Compensation Letter, dated February 20, 2024, from the Registrant to (Caribou Biosciences, Inc., Filed With SEC on March 11, 2024)
- Compensation Letter, dated February 20, 2024, from the Registrant to (Caribou Biosciences, Inc., Filed With SEC on March 11, 2024)
- Compensation Letter, dated February 20, 2024, from the Registrant to (Caribou Biosciences, Inc., Filed With SEC on March 11, 2024)
- Compensation Letter, dated February 20, 2024, from the Registrant to (Caribou Biosciences, Inc., Filed With SEC on March 11, 2024)
- Compensation Letter, dated (Caribou Biosciences, Inc., Filed With SEC on March 11, 2024)
- Amended and Restated Non-Employee Director Compensation Policy (Janux Therapeutics, Inc., Filed With SEC on March 8, 2024)
- Outside Director Compensation Policy (as amended and restated on February 26, 2024) (IGM Biosciences, Inc., Filed With SEC on March 7, 2024)
- Outside Director Compensation Policy (SOLENO THERAPEUTICS INC, Filed With SEC on March 7, 2024)
- Non-Employee Director Compensation Program (SELECTA BIOSCIENCES INC, Filed With SEC on March 7, 2024)